Has COVID-19 pandemic proven more hostile to developing economies?

India-based Bharat Biotech will evaluate its COVID-19 vaccine in a Phase 2/3 clinical trial on children in the 2-18 age group. According to PTI report, the study will be performed on approximately 525 participants at several sites in India. Recent...

Summary With the development of COVID-19 vaccines and medicines, scientists are now aiming to improve therapeutics and exploring different delivery routes. Amcyte Pharma’s algae-derived NasitrolTM nasal spray has demonstrated efficacy in ...

Summary Viruses continually mutate, and sometimes new variants emerge that can persist for a longer time. Experts warn that more COVID-19 variants are anticipated to arise in the upcoming months. Meanwhile, Moderna’s new booster shot has...

Summary With the surmounting COVID-19 cases, the developing countries are demanding patent exemptions on items, including vaccines, diagnostic kits, and ventilators, to fight the COVID-19 pandemic. The patent waiver will help emerging nations m...

The deadly coronavirus pandemic was first reported from Wuhan, China in December 2019 and spread across the globe leaving economies of the biggest countries come to a standstill. No one had predicted what the outbreak could cost, and sadly it did c...

Source: Moonhonor, Shutterstock Summary The EU Commission has opted not to renew contracts for the COVID-19 vaccine from Oxford-AstraZeneca and Johnson & Johnson. Researchers at the University of Oxford introduced a Com-Cov study to evalua...

Source: solarseven, Shutterstock  Shares of Johnson & Johnson (NYSE: JNJ) fell 1.34 percent on Tuesday after the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) recommended pausing the compan...

Source: diy13, Shutterstock Summary European Union (EU) plans to roll out a digital travel certificate to start foreign travel for all EU citizens. The certificate would be valid till WHO confirms the end of the COVID-19 pandemic. The objecti...

e links of blood clots after the administration of AstraZeneca’s jab. The COVID-19 vaccine manufactured by Oxford University and AstraZeneca Plc (LON:AZN) has been a part of controversy amid several nations suspending the vaccine's use, in...

Source: solarseven, Shutterstock Summary Pfizer-BioNTech’s COVID-19 vaccine has proved to be 100% effective in young adolescents (12-15 years) in Phase 3 clinical study. The two partners plan to submit these data to the US FDA and t...